Showing results (231-240 of 254) with videos related to

Sort By:
Pageof 26
Journal of Medicinal Chemistry|November 28, 2018
Highly Potent 17β-HSD2 Inhibitors with a Promising Pharmacokinetic Profile for Targeted Osteoporosis TherapyLorenz Siebenbuerger, Victor Hernandez-Olmos, Ahmed S Abdelsamie, et al.
Journal of the American Chemical Society|December 23, 2017
Glycomimetic, Orally Bioavailable LecB Inhibitors Block Biofilm Formation of Pseudomonas aeruginosaRoman Sommer, Stefanie Wagner, Katharina Rox, et al.
Biochemical Pharmacology|December 30, 2019
Profiling of anabolic androgenic steroids and selective androgen receptor modulators for interference with adrenal steroidogenesisMelanie Patt, Katharina R Beck, Tobias Di Marco, et al.
ACS Infectious Diseases|September 4, 2020
Evaluation of Bacterial RNA Polymerase Inhibitors in a Staphylococcus aureus-Based Wound Infection Model in SKH1 MiceJörg Haupenthal, Yannik Kautz, Walid A M Elgaher, et al.
Microbiologyopen|April 19, 2017
Regulation of Burkholderia cenocepacia biofilm formation by RpoN and the c-di-GMP effector BerBMustafa Fazli, Morten Rybtke, Elisabeth Steiner, et al.
Journal of Medicinal Chemistry|May 30, 2020
N-Aryl-3-mercaptosuccinimides as Antivirulence Agents Targeting Pseudomonas aeruginosa Elastase and Clostridium CollagenasesJelena Konstantinović, Samir Yahiaoui, Alaa Alhayek, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 12, 2017
CYP17A1-independent production of the neurosteroid-derived 5α-pregnan-3β,6α-diol-20-one in androgen-responsive prostate cancer cell lines under serum starvation and inhibition by AbirateroneAntonio G Gomes de Mello Martins, Giuseppe Allegretta, Gerhard Unteregger, et al.
The EMBO Journal|November 18, 2006
Allosteric activation of the protein kinase PDK1 with low molecular weight compoundsMatthias Engel, Valerie Hindie, Laura A Lopez-Garcia, et al.
Journal of Medicinal Chemistry|January 16, 2019
Targeted Endocrine Therapy: Design, Synthesis, and Proof-of-Principle of 17β-Hydroxysteroid Dehydrogenase Type 2 Inhibitors in Bone Fracture HealingAhmed S Abdelsamie, Steven Herath, Yannik Biskupek, et al.
Pageof 26